Race to save lives during sudden, deadly lung crises
Disease control
Recruiting now
This study is testing if adding intravenous immunoglobulin (IVIG) to standard hospital care helps patients with idiopathic pulmonary fibrosis (IPF) who are hospitalized for a sudden, severe worsening of their lung disease. The main goal is to see if IVIG can reduce deaths in the …
Phase: PHASE3 • Sponsor: Argyrios Tzouvelekis • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC